Baltimore, MD, United States of America

George Steven Bova

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Johns Hopkins University, Other. Active years: 2002-2024.


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2002-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: George Steven Bova: Innovator in Prostate Cancer Research

Introduction

George Steven Bova is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical research, particularly in the area of prostate cancer. With a total of 4 patents, Bova's work focuses on innovative diagnostic and therapeutic methods.

Latest Patents

Bova's latest patents include compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants. These inventions feature diagnostic and therapeutic methods and compositions that utilize androgen receptor variant proteins and nucleic acid molecules. These molecules have increased expression in androgen-related diseases or disorders, highlighting their potential in medical applications.

Career Highlights

Throughout his career, George Steven Bova has worked with prestigious institutions, including Johns Hopkins University. His research has been pivotal in advancing the understanding and treatment of prostate cancer, making him a key figure in this field.

Collaborations

Bova has collaborated with esteemed colleagues, including Jun Luo and William B. Isaacs. These partnerships have further enriched his research and contributed to the development of innovative solutions in cancer treatment.

Conclusion

George Steven Bova's contributions to prostate cancer research through his patents and collaborations underscore his importance as an inventor in the medical field. His work continues to pave the way for advancements in diagnostic and therapeutic methods.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…